Biotech

All Articles

Editas cashes in on Vertex Cas9 licensing legal rights for $57M

.Against the scenery of a Cas9 license struggle that rejects to pass away, Editas Medication is cash...

Ultragenyx fine-tunes gene therapy application to dial up efficacy

.A minority of clients taking Ultragenyx Pharmaceutical's Wilson ailment genetics treatment UX701 ha...

Biopharma discharge cost stabilizes in Q3: Fierce Biotech review

.As summer months warmth turns to cool down winds, hopes that this year will take wide-spread field ...

J &amp J falls period 2 dengue applicant in most current switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its infectious disease pipe has stated one more victim s...

Relay loses 10% of personnel after earlier cutbacks in July

.Preciseness medication biotech Relay Rehabs is actually shedding around 10% of its workforce in ini...

Pentixapharm ratings $22M IPO to deposit radiopharma tests

.Pentixapharm has actually brought in practically 20 million europeans ($ 22 million) coming from an...

Lundbeck water faucets Charles River for AI-enabled neuro medicine invention

.Lundbeck has utilized Charles Stream Laboratories' artificial intelligence functionalities to assis...

Big pharma, biotech 'won't necessarily be symbiotic' in AI: S&ampP

.Big Pharma is actually investing intensely in AI to reduce development timetables as well as foster...

I &amp I biotech Triveni increases $115M for preclinical antibodies

.Triveni Bio has trapped $115 million in collection B funds to accelerate preclinical antitoxin syst...

IGM turns coming from cancer to autoimmune, shocking C-suite

.IGM Biosciences ended in 2013 giving up team and also enhancing its cancer cells pipeline. Now, the...